Table 1.
Clinicopathological characteristics of patients with stage IC ovarian granulosa cell tumors stratified by the administration of adjuvant chemotherapy (CT).
| No CT | CT | p value | |
|---|---|---|---|
| Age (median) | 51 yrs. | 48 yrs. | 0.005 |
| Age (yrs) <=30 31–40 41–50 51–60 60+ |
22 (6.7%) 66 (20.2%) 73 (22.4%) 72 (22.1%) 93 (28.5%) |
24 (14.5%) 29 (17.5%) 44 (26.5%) 42 (25.3%) 27 (16.3%) |
0.004 |
| Medical co-morbidities No Yes |
264 (81%) 62 (19%) |
142 (85.5%) 24 (14.5%) |
0.21 |
| History of other tumor No Yes |
290 (89%) 36 (11%) |
154 (92.8%) 12 (7.2%) |
0.18 |
| Race White Non-white/Unknown |
225 (69%) 101 (31%) |
121 (72.9%) 45 (27.1%) |
0.37 |
| Year of diagnosis 2004–2006 2007–2009 2010–2012 2013–2015 |
68 (20.9%) 74 (22.7%) 88 (27%) 96 (29.4%) |
20 (12%) 34 (20.5%) 50 (30.1%) 62 (37.3%) |
0.056 |
| Reporting facility Type Academic Other Unknown |
107 (32.8%) 142 (43.6%) 77 (23.6%) |
37 (22.3%) 79 (47.6%) 50 (30.1%) |
0.041 |
| Insurance Private Medicaid/Medicare/Government Uninsured/Unknown |
190 (58.3%) 105 (32.2%) 31 (9.5%) |
120 (72.3%) 39 (23.5%) ^ |
0.006 |
| Median Income* <38,000 $ 38,000–47,999 $ 48,000–62,999 $ > = 63,000 $ |
71 (22%) 75 (23.2%) 94 (29.1%) 83 (25.7%) |
35 (21.1%) 44 (26.5%) 46 (27.7%) 41 (24.7%) |
0.89 |
| LND Yes No/Unknown |
164 (50.3%) 162 (49.7%) |
96 (57.8%) 70 (42.2%) |
0.11 |
| Hysterectomy& Yes No |
192 (63.4%) 111 (36.6%) |
95 (64.6%) 52 (35.4%) |
0.79 |
| Size < 10 cm > = 10 cm Unknown |
152 (46.6%) 139 (42.6%) 35 (10.7%) |
57 (34.3%) 87 (52.4%) 22 (13.3%) |
0.033 |
^ suppressed n < 10, * missing for 3 cases, &missing for 42 cases.